Self-assembly of soft materials is broadly considered an attractive means of generating nanoscale structures and patterns over large areas. However, the spontaneous formation of equilibrium nanostructures in response to temperature and concentration changes, for example, must be guided to yield the long-range order and orientation required for utility in a given scenario. In this review we examine directed self-assembly (DSA) of block copolymers (BCPs) as canonical examples of nanostructured soft matter systems which are additionally compelling for creating functional materials and devices. We survey well established and newly emerging DSA methods from a tutorial perspective. Special emphasis is given to exploring underlying physical phenomena, identifying prototypical BCPs that are compatible with different DSA techniques, describing experimental methods and highlighting the attractive functional properties of block copolymers overall. Finally we offer a brief perspective on some unresolved issues and future opportunities in this field.

The self-assembly of diblock copolymers provides a convenient route to the formation of mechanically robust films with precise and tunable periodic arrangements of two physically demixed but chemically linked polymeric materials. Chemoselective transport membranes may be realized from such films by selective partitioning of an active species into one of the polymer domains. Here, lithium ions were selectively sequestered within the poly(ethylene oxide) block of a liquid crystalline diblock copolymer to form polymer electrolyte membranes. Optimization of the membrane conductivity mandates alignment of self-assembled structures such that conduction occurs via direct as opposed to tortuous transport between exterior surfaces. We show here that magnetic fields can be used in a very simple and scalable manner to produce highly aligned hexagonally packed cylindrical microdomains in such membranes over macroscopic areas. We systematically explore the dependence of the ionic conductivity of the membrane on both temperature and magnetic field strength. A surprising order of magnitude increase in conductivity relative to the nonaligned case is found in films aligned at the highest magnetic field strengths, 6 T. The conductivity of field aligned samples shows a nonmonotonic dependence on temperature, with a marked decrease on heating in the proximity of the order-disorder transition of the system before increasing again at elevated temperatures. The data suggest that domain-confined transport in hexagonally packed cylindrical systems differs markedly in anisotropy by comparison with lamellar systems.

Objective-Heparin-induced thrombocytopenia (HIT) is a prothrombotic drug reaction caused by antibodies that recognize positively charged platelet factor 4 (PF4), bound to the polyanion, heparin. The resulting immune complexes activate platelets. Unfractionated heparin (UFH) causes HIT more frequently than low-molecular-weight heparin (LMWH), whereas the smallest heparin-like molecule (the pentasaccharide, fondaparinux), induces anti-PF4/heparin antibodies as frequently as LMWH, but without exhibiting cross-reactivity with these antibodies. To better understand these findings, we analyzed the molecular structure of the complexes formed between PF4 and UFH, LMWH, or fondaparinux. Methods and Results-By atomic force microscopy and photon correlation spectroscopy, we show that with any of the 3 polyanions, but in the order, UFHϾLMWHϾ Ͼfondaparinux-PF4 forms clusters in which PF4 tetramers become closely apposed, and to which anti-PF4/heparin antibodies bind. By immunoassay, HIT antibodies bind strongly to PF4/H/PF4 complexes, but only weakly to single PF4/heparin molecules. Conclusion-HIT antigens are formed when charge neutralization by polyanion allows positively charged PF4 tetramers to undergo close approximation. Whereas such a model could explain why all 3 polyanions form antibodies with similar specificities, the striking differences in the relative size and amount of complexes formed likely correspond to the observed differences in immunogenicity (UFHϾLMWHϷfondaparinux) and clinically relevant cross-reactivity (UFHϾLMWHϾ Ͼfondaparinux

Block copolymers (BCPs) offer an exciting range of structures and functions that are of potential utility in existing as well as emerging technologies. Although this is generally acknowledged, with few exceptions, viable strategies for establishing scalable and robust control of BCP microstructure are underdeveloped. Magnetic field alignment offers great potential in this regard. The physics bears much in common with electric field alignment, but the absence of dielectric breakdown concerns and the more flexible, space pervasive nature of magnetic fields make it possible to design processes for high-throughput fabrication of well-ordered films with appro-priate materials. In this perspective, we highlight the use of magnetic fields for control of microstructure in BCPs as well as polymer nanocomposites involving anisotropic nanomaterials. A brief review of efforts to date is given. Open questions related to field-polymer interactions and future directions for magnetic alignment of these systems are discussed. V C 2011 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 50: 2-8, 2012

Amorphous nanoparticles (a-NPs) have physicochemical properties distinctly different from those of the corresponding bulk crystals; for example, their solubility is much higher. However, many materials have a high propensity to crystallize and are difficult to formulate in an amorphous structure without stabilizers. We fabricated a microfluidic nebulator that can produce amorphous NPs from a wide range of materials, even including pure table salt (NaCl). By using supersonic air flow, the nebulator produces drops that are so small that they dry before crystal nuclei can form. The small size of the resulting spray-dried a-NPs limits the probability of crystal nucleation in any given particle during storage. The kinetic stability of the a-NPs—on the order of months—is advantageous for hydrophobic drug molecules.